Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Fuller

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Radiology|December 1, 1982
EOE-13 in the detection of hepatosplenic lymphomaJ L Thomas, M E Bernardino, M Vermess, et al.
Cancer|March 15, 1990
The intergroup Hodgkin's disease in children. A study of stages I and IIE A Gehan, M P Sullivan, L M Fuller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphomaJ F Seymour, P McLaughlin, L M Fuller, et al.
Radiology|September 2, 1998
Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997M T Vlachaki, C S Ha, F B Hagemeister, et al.
Blood|August 1, 1989
Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival dataW S Velasquez, S Jagannath, S L Tucker, et al.
Surgery|September 1, 1984
Complications related to 234 staging laparotomies performed in the Intergroup Hodgkin's Disease in Childhood studyD M Hays, J L Ternberg, T T Chen, et al.
Blood|March 1, 1991
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapyW S Velasquez, L M Fuller, S Jagannath, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiationL M Fuller, M J Krasin, W S Velasquez, et al.
Cancer|March 15, 1980
Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapyL M Fuller, J F Gamble, W S Velazquez, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
Further follow-up of results of treatment in 90 laparotomy-negative stage I and II Hodgkin's disease patients: significance of mediastinal and non-mediastinal presentationsL M Fuller, H Madoc-Jones, F B Hagemeister, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Radiology|December 1, 1982
EOE-13 in the detection of hepatosplenic lymphomaJ L Thomas, M E Bernardino, M Vermess, et al.
Cancer|March 15, 1990
The intergroup Hodgkin's disease in children. A study of stages I and IIE A Gehan, M P Sullivan, L M Fuller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphomaJ F Seymour, P McLaughlin, L M Fuller, et al.
Radiology|September 2, 1998
Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997M T Vlachaki, C S Ha, F B Hagemeister, et al.
Blood|August 1, 1989
Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival dataW S Velasquez, S Jagannath, S L Tucker, et al.
Surgery|September 1, 1984
Complications related to 234 staging laparotomies performed in the Intergroup Hodgkin's Disease in Childhood studyD M Hays, J L Ternberg, T T Chen, et al.
Blood|March 1, 1991
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapyW S Velasquez, L M Fuller, S Jagannath, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiationL M Fuller, M J Krasin, W S Velasquez, et al.
Cancer|March 15, 1980
Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapyL M Fuller, J F Gamble, W S Velazquez, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
Further follow-up of results of treatment in 90 laparotomy-negative stage I and II Hodgkin's disease patients: significance of mediastinal and non-mediastinal presentationsL M Fuller, H Madoc-Jones, F B Hagemeister, et al.
Pageof 12